The Effect of Nalbuphine Extended-Release (NAL ER) on Cough in Participants With Refractory Chronic Cough (RCC)
Abroad (travel likely)RecruitingPHASE2
Conditions
Refractory Chronic Cough
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
BLC Clinical Research, Burlington, Canada
Diex Recherche - Quebec, Québec, Canada
Clinique Specialisee En Allergie De La Capitale, Québec, Canada
Centre D'Investigation Clinique Mauricie Inc (CIC Mauricie), Trois-Rivières, Canada
Diex Recherche-Victoriaville, Victoriaville, Canada
Study leads
Chief Development Officer
Study Director
Trevi Therapeutics